New Jersey A 5948: Limits amount paid by covered persons for purchase of insulin drugs and epinephrine; requires Division of Consumer Affairs to investigate insulin prices.

Status: Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee (as of 2019-11-18)

State: New Jersey · Session: 218 · Bill: A 5948

Subjects: PHARMACEUTIC, STATE DEPTS

Sponsors: McKnight, Angela V., Vainieri Huttle, Valerie

View New Jersey A 5948 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.